Introducing PerennialLearn more

The Future of Genomics is On Chain

We are a public company on the Canadian Securities Exchange. Our flagship healthcare product, Perennial, is now live!

Launch App
Moss Genomics Perennial Dashboard

Latest News

Moss Genomics Advances Blockchain Integration Strategy

The Company has contributed 200 ETH with a commitment to contribute an additional 800 ETH to the presale of STRAT, an on-chain smart contract that enables ETH-based capital flows through algorithmic expansion and redemption mechanisms...

Read more

Moss Genomics Announces Strategic Investment in Genomes.io

Moss Genomics Inc. announces that it has entered into a non-binding term sheet for a strategic, non-controlling equity investment in Genomes.io...

Read more

Moss Genomics Announces Private Placement and Agreement to Acquire Ethereum

Moss Genomics Inc. announces a non-brokered private placement of up to 2,000,000 common shares at price of $0.18 per share for aggregate proceeds of up to $360,000...

Read more

Moss Genomics Provides Corporate Update and Announces Shift in Business Strategy

Moss Genomics Inc. (CSE: MOSS) (FSE: F73) is pleased to provide an update on the Company's operations and business strategy...

Read more

Moss Genomics Inc. Announces Successful German Listing on the Frankfurt Stock Exchange (FSE)

Moss Genomics Inc. (CSE: MOSS) (FSE: F73) is pleased to announce that it has successfully listed its shares on the Frankfurt Stock Exchange (FSE) under the ticker symbol F73...

Read more

Canadian Company Moss Genomics Announces Agreement to Acquire Ethereum, Appoints Jack Liu as CEO

Moss Genomics Inc. announces agreement to acquire 160 ETH and appoints Jack Liu as CEO and Director, marking a significant strategic shift...

Read more